Autopsy report · NCT03333551

Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy

“slow recruitment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years before it started.
• Ran for about 2 years 7 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 3 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Medical College of Wisconsin

Sponsor type

University, hospital or other

Conditions

Cardiac Amyloidosis

Interventions

F18 Florbetapir (amyvid) cardiac PET/CT imaging

Participants

4

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.